C700-2379 Screening compound: 1-{pyrrolo[1,2-a]quinoxalin-4-yl}-4-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperazine

C700-2379 Screening compound: 1-{pyrrolo[1,2-a]quinoxalin-4-yl}-4-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperazine
C700-2379 Screening compound: 1-{pyrrolo[1,2-a]quinoxalin-4-yl}-4-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound C700-2379
1-{pyrrolo[1,2-a]quinoxalin-4-yl}-4-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C700-2379

Molecular Formula

C25H26N4O2S (C25 H26 N4 O2 S)

Compound Name

1-{pyrrolo[1,2-a]quinoxalin-4-yl}-4-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperazine

IUPAC name

1-{pyrrolo[12-a]quinoxalin-4-yl}-4-(5678-tetrahydronaphthalene-2-sulfonyl)piperazine

SMILES

O=S(c1cc(CCCC2)c2cc1)(N(CC1)CCN1c1nc(cccc2)c2n2c1ccc2)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.513

Distribution Coefficient, logD

5.486

Water Solubility, LogSw

-5.83

Polar Surface Area

42.598

Acid Dissociation Constant (pKa)

24.32

Base Dissociation Constant (pKb)

6.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

C700-2379 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C700-2379 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C700-2379?
Check Price and Availability of C700-2379, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C700-2379 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C700-2379
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C700-2379
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C700-2379 available by request